Cargando…
Monitoring immunomodulation strategies in type 1 diabetes
Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease. Short-term treatment with agents targeting T cells, B cells and inflammatory cytokines to modify the disease course resulted in a short-term pause in disease activity. Lessons learnt from these trials will be discussed in this review. It...
Autores principales: | Krishnamurthy, Balasubramanian, Lacorcia, Matthew, Kay, Thomas W. H., Thomas, Helen E., Mannering, Stuart I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279879/ https://www.ncbi.nlm.nih.gov/pubmed/37346035 http://dx.doi.org/10.3389/fimmu.2023.1206874 |
Ejemplares similares
-
IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4(+) T Cell Migration
por: Scott, Nicholas A., et al.
Publicado: (2018) -
Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes
por: Mannering, Stuart I., et al.
Publicado: (2021) -
Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
por: Jhala, Gaurang, et al.
Publicado: (2021) -
Insulin teaches a new lesson in tolerance
por: Kay, Thomas W H, et al.
Publicado: (2009) -
Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes
por: Wiedemann, Marie, et al.
Publicado: (2020)